ReviewPolymers2025
Fungal and Microalgal Chitin: Structural Differences, Functional Properties, and Biomedical Applications.
Review in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Bioactive Coatings with Antimicrobial Activity fromMolecules (Basel, Switzerland) · 2026Review
- Mycogenic Nanomaterials: What Fungal Nanoparticles Promise and What Still Holds Them Back.Journal of fungi (Basel, Switzerland) · 2026Review
- Molecular Mechanisms of Mucormycosis Pathogenesis: Host-Pathogen Interactions and Immune Evasion.Pathogens (Basel, Switzerland) · 2026Review
- Comparative Metabolomics Reveals the Nutritional Merit and Metabolic Basis of a Naturally Occurring White Variant inFoods (Basel, Switzerland) · 2026Article
- An Assessment of Fabrication, Properties, and Medical Applications of Chitosan-Nanometal Coatings.Materials (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Chitin, one of the most abundant natural polysaccharides, has gained increasing attention for its structural diversity and potential in biomedicine, agriculture, food packaging, and advanced materials. Conventional chitin production from crustacean shell waste faces limitations, including seasonal availability, allergenic protein contamination, heavy metal residues, and environmentally harmful demineralization processes. Chitin from fungi and microalgae provides a sustainable and chemically versatile alternative. Fungal chitin, generally present in the α-polymorph, is embedded in a chitin-glucan-protein matrix that ensures high crystallinity, mechanical stability, and compatibility for biomedical applications. Microalgal β-chitin, particularly from diatoms, is secreted as high-aspect-ratio microrods and nanofibrils with parallel chain packing, providing enhanced reactivity and structural integrity that are highly attractive for functional materials. Recent progress in green extraction technologies, including enzymatic treatments, ionic liquids, and deep eutectic solvents, enables the recovery of chitin with reduced environmental burden while preserving its native morphology. By integrating sustainable sources with environmentally friendly processing methods, fungal and microalgal chitin offer unique structural polymorphs and tunable properties, positioning them as a promising alternative to crustacean-derived chitin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.